Northern Trust’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $183M | Buy |
731,283
+4,771
| +0.7% | +$1.19M | 0.02% | 510 |
|
|
2025
Q4 | $200M | Sell |
726,512
-18,379
| -2% | -$5.03M | 0.03% | 491 |
|
|
2025
Q3 | $195M | Sell |
744,891
-5,039
| -0.7% | -$1.22M | 0.03% | 499 |
|
|
2025
Q2 | $164M | Sell |
749,930
-8,316
| -1% | -$1.78M | 0.02% | 542 |
|
|
2025
Q1 | $170M | Sell |
758,246
-10,602
| -1% | -$2.92M | 0.03% | 516 |
|
|
2024
Q4 | $252M | Buy |
768,848
+109,481
| +17% | +$34.5M | 0.04% | 407 |
|
|
2024
Q3 | $198M | Sell |
659,367
-46,248
| -7% | -$14.2M | 0.03% | 439 |
|
|
2024
Q2 | $232M | Sell |
705,615
-14,335
| -2% | -$5.07M | 0.04% | 388 |
|
|
2024
Q1 | $285M | Sell |
719,950
-51,695
| -7% | -$19.1M | 0.05% | 346 |
|
|
2023
Q4 | $272M | Sell |
771,645
-34,458
| -4% | -$12.2M | 0.05% | 349 |
|
|
2023
Q3 | $302M | Buy |
806,103
+33,867
| +4% | +$13.1M | 0.06% | 312 |
|
|
2023
Q2 | $295M | Sell |
772,236
-74,344
| -9% | -$26.6M | 0.06% | 319 |
|
|
2023
Q1 | $293M | Buy |
846,580
+11,589
| +1% | +$3.39M | 0.06% | 319 |
|
|
2022
Q4 | $197M | Buy |
834,991
+22,589
| +3% | +$5.35M | 0.04% | 406 |
|
|
2022
Q3 | $200M | Sell |
812,402
-15,021
| -2% | -$4.58M | 0.05% | 371 |
|
|
2022
Q2 | $250M | Sell |
827,423
-50,264
| -6% | -$16.4M | 0.05% | 325 |
|
|
2022
Q1 | $360M | Sell |
877,687
-93,037
| -10% | -$36.4M | 0.06% | 293 |
|
|
2021
Q4 | $455M | Buy |
970,724
+5,206
| +0.5% | +$2.24M | 0.07% | 256 |
|
|
2021
Q3 | $410M | Buy |
965,518
+48,592
| +5% | +$20.5M | 0.07% | 255 |
|
|
2021
Q2 | $329M | Sell |
916,926
-6,613
| -0.7% | -$2.18M | 0.06% | 308 |
|
|
2021
Q1 | $260M | Buy |
923,539
+72,144
| +8% | +$20.6M | 0.05% | 343 |
|
|
2020
Q4 | $241M | Sell |
851,395
-14,037
| -2% | -$3.94M | 0.05% | 348 |
|
|
2020
Q3 | $238M | Buy |
865,432
+8,149
| +1% | +$2.16M | 0.05% | 313 |
|
|
2020
Q2 | $195M | Buy |
857,283
+141,991
| +20% | +$27.9M | 0.05% | 352 |
|
|
2020
Q1 | $109M | Buy |
715,292
+19,027
| +3% | +$2.93M | 0.03% | 452 |
|
|
2019
Q4 | $105M | Buy |
696,265
+107,875
| +18% | +$15.7M | 0.02% | 575 |
|
|
2019
Q3 | $83.4M | Sell |
588,390
-2,261
| -0.4% | -$311K | 0.02% | 639 |
|
|
2019
Q2 | $73.9M | Sell |
590,651
-12,364
| -2% | -$1.46M | 0.02% | 715 |
|
|
2019
Q1 | $66.5M | Buy |
603,015
+11,082
| +2% | +$1.15M | 0.02% | 756 |
|
|
2018
Q4 | $58M | Sell |
591,933
-3,027
| -0.5% | -$328K | 0.02% | 757 |
|
|
2018
Q3 | $73.5M | Sell |
594,960
-1,680
| -0.3% | -$188K | 0.02% | 726 |
|
|
2018
Q2 | $59.2M | Sell |
596,640
-4,713
| -0.8% | -$434K | 0.02% | 858 |
|
|
2018
Q1 | $53.1M | Sell |
601,353
-2,497
| -0.4% | -$234K | 0.01% | 946 |
|
|
2017
Q4 | $59.6M | Sell |
603,850
-31,606
| -5% | -$3.1M | 0.02% | 851 |
|
|
2017
Q3 | $61.2M | Sell |
635,456
-9,739
| -2% | -$881K | 0.02% | 808 |
|
|
2017
Q2 | $61M | Buy |
645,195
+3,523
| +0.5% | +$324K | 0.02% | 783 |
|
|
2017
Q1 | $52.4M | Buy |
641,672
+7,686
| +1% | +$643K | 0.02% | 890 |
|
|
2016
Q4 | $53.8M | Sell |
633,986
-138,189
| -18% | -$10.9M | 0.02% | 832 |
|
|
2016
Q3 | $57.5M | Sell |
772,175
-40,535
| -5% | -$3.22M | 0.02% | 769 |
|
|
2016
Q2 | $61.7M | Sell |
812,710
-516,362
| -39% | -$37.6M | 0.02% | 688 |
|
|
2016
Q1 | $90.6M | Buy |
1,329,072
+20,522
| +2% | +$1.23M | 0.03% | 524 |
|
|
2015
Q4 | $78.8M | Buy |
1,308,550
+3,731
| +0.3% | +$224K | 0.03% | 568 |
|
|
2015
Q3 | $70.6M | Buy |
1,304,819
+241,133
| +23% | +$14.1M | 0.02% | 606 |
|
|
2015
Q2 | $61.8M | Sell |
1,063,686
-17,743
| -2% | -$990K | 0.02% | 717 |
|
|
2015
Q1 | $65.1M | Sell |
1,081,429
-27,613
| -2% | -$1.47M | 0.02% | 693 |
|
|
2014
Q4 | $59M | Sell |
1,109,042
-10,429
| -0.9% | -$522K | 0.02% | 725 |
|
|
2014
Q3 | $50.1M | Buy |
1,119,471
+120,215
| +12% | +$5.11M | 0.02% | 794 |
|
|
2014
Q2 | $42.1M | Sell |
999,256
-184,498
| -16% | -$7.9M | 0.01% | 915 |
|
|
2014
Q1 | $52.1M | Buy |
1,183,754
+19,417
| +2% | +$914K | 0.02% | 790 |
|
|
2013
Q4 | $57.1M | Buy |
1,164,337
+428,898
| +58% | +$20.1M | 0.02% | 696 |
|
|
2013
Q3 | $30.3M | Sell |
735,439
-458,963
| -38% | -$17.5M | 0.01% | 1101 |
|
|
2013
Q2 | $42M | Buy |
+1,194,402
| New | +$39.3M | 0.02% | 774 |
|
Other funds holding WST
VCM
VPM
GIM
Northern Trust's WST Position: Q1 2026 in Review
Northern Trust increased its West Pharmaceutical (WST) stake by 0.66% in Q1 2026, buying an estimated $1.19M and bringing the position to 731,283 shares worth $183M. The position accounts for 0.02% of the portfolio, ranked #510.
Northern Trust first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $455M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Northern Trust held 731,283 shares of West Pharmaceutical worth $183M as of Q1 2026.
- Northern Trust bought 4,771 West Pharmaceutical shares in Q1 2026, an estimated $1.19M.
- West Pharmaceutical made up 0.02% of Northern Trust's portfolio in Q1 2026, its #510 holding.
- Northern Trust first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's West Pharmaceutical position peaked at $455M in Q4 2021.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.